Poland· PL-100017463
10% Dekstran 40 000 Fresenius
A dextran product containing dextranum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dextran is registered in 5 of 19 countries.
Countries holding a registration under ATC B05AA05 (dextran), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Dextran · ATC B05AA05
5 / 19 countries
- Denmark
- Finlandprice
- Icelandprice
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Dextranum
- Manufacturer
- Fresenius Kabi Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B05AA05
- ATC class
- Dextran
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909990212729
- gtin05909990212736
- gtin05909990212743
- gtin05909990671557
- gtin05909990671564
- gtin05909990212712
- gtin05909991375942
- gtin05909991375959
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for dextran.
Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dextran · interactions on record
25 records
- 22 severe
- 3 moderate
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dextran in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ba2d3f4-51c1-49ba-a91b-dcc2bde6c84b GET /v1/drugs/5ba2d3f4-51c1-49ba-a91b-dcc2bde6c84b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "100 mg/ml",
"packaging": "05909990212729 ¦ Lz ¦ 2959\n1 butelka 500 ml\n05909990212736 ¦ Lz ¦ Skasowane ¦ 14958\n1 worek 250 ml\n05909990212743 ¦ Lz ¦ Skasowane ¦ 14962\n1 worek 500 ml\n05909990671557 ¦ Lz ¦ Skasowane ¦ 46805\n1 poj. 250 ml\n05909990671564 ¦ Lz ¦ Skasowane ¦ 46806\n1 poj. 500 ml\n05909990212712 ¦ Lz ¦ 58222\n1 butelka 250 ml\n05909991375942 ¦ Lz ¦ 128601\n12 butelek 250 ml\n05909991375959 ¦ Lz ¦ 128602\n12 butelek 500 ml",
"substance": "Dextranum 100 g",
"common_name": "Dextranum",
"pl_product_id": "100017463",
"pozwolenie_nr": "02127",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about dextran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.